Literature DB >> 19585593

In vivo cytometry of antigen-specific t cells using 19F MRI.

Mangala Srinivas1, Michael S Turner, Jelena M Janjic, Penelope A Morel, David H Laidlaw, Eric T Ahrens.   

Abstract

Noninvasive methods to image the trafficking of phenotypically defined immune cells are paramount as we attempt to understand adaptive immunity. A (19)F MRI-based methodology for tracking and quantifying cells of a defined phenotype is presented. These methods were applied to a murine inflammation model using antigen-specific T cells. The T cells that were intracellularly labeled ex vivo with a perfluoropolyether (PFPE) nanoemulsion and cells were transferred to a host receiving a localized inoculation of antigen. Longitudinal (19)F MRI over 21 days revealed a dynamic accumulation and clearance of T cells in the lymph node (LN) draining the antigen. The apparent T-cell numbers were calculated in the LN from the time-lapse (19)F MRI data. The effect of in vivo T-cell division on the (19)F MRI cell quantification accuracy was investigated using fluorescence assays. Overall, in vivo cytometry using PFPE labeling and (19)F MRI is broadly applicable to studies of whole-body cell biodistribution.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19585593      PMCID: PMC2763624          DOI: 10.1002/mrm.22063

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  21 in total

1.  Cancer regression in patients after transfer of genetically engineered lymphocytes.

Authors:  Richard A Morgan; Mark E Dudley; John R Wunderlich; Marybeth S Hughes; James C Yang; Richard M Sherry; Richard E Royal; Suzanne L Topalian; Udai S Kammula; Nicholas P Restifo; Zhili Zheng; Azam Nahvi; Christiaan R de Vries; Linda J Rogers-Freezer; Sharon A Mavroukakis; Steven A Rosenberg
Journal:  Science       Date:  2006-08-31       Impact factor: 47.728

Review 2.  A non-invasive approach to detecting organ rejection by MRI: monitoring the accumulation of immune cells at the transplanted organ.

Authors:  Chien Ho; T Kevin Hitchens
Journal:  Curr Pharm Biotechnol       Date:  2004-12       Impact factor: 2.837

Review 3.  Targeting cells with MR imaging probes based on paramagnetic Gd(III) chelates.

Authors:  S Aime; A Barge; C Cabella; S Geninatti Crich; E Gianolio
Journal:  Curr Pharm Biotechnol       Date:  2004-12       Impact factor: 2.837

4.  In vivo imaging platform for tracking immunotherapeutic cells.

Authors:  Eric T Ahrens; Rafael Flores; Hongyan Xu; Penelope A Morel
Journal:  Nat Biotechnol       Date:  2005-07-24       Impact factor: 54.908

Review 5.  Cellular magnetic resonance imaging: current status and future prospects.

Authors:  Ali S Arbab; Wei Liu; Joseph A Frank
Journal:  Expert Rev Med Devices       Date:  2006-07       Impact factor: 3.166

6.  A phase I study on adoptive immunotherapy using gene-modified T cells for ovarian cancer.

Authors:  Michael H Kershaw; Jennifer A Westwood; Linda L Parker; Gang Wang; Zelig Eshhar; Sharon A Mavroukakis; Donald E White; John R Wunderlich; Silvana Canevari; Linda Rogers-Freezer; Clara C Chen; James C Yang; Steven A Rosenberg; Patrick Hwu
Journal:  Clin Cancer Res       Date:  2006-10-15       Impact factor: 12.531

Review 7.  Iron oxide MR contrast agents for molecular and cellular imaging.

Authors:  Jeff W M Bulte; Dara L Kraitchman
Journal:  NMR Biomed       Date:  2004-11       Impact factor: 4.044

8.  A phase 1 trial of donor lymphocyte infusions expanded and activated ex vivo via CD3/CD28 costimulation.

Authors:  David L Porter; Bruce L Levine; Nancy Bunin; Edward A Stadtmauer; Selina M Luger; Steven Goldstein; Alison Loren; Julie Phillips; Sunita Nasta; Alexander Perl; Steven Schuster; Donald Tsai; Ambika Sohal; Elizabeth Veloso; Stephen Emerson; Carl H June
Journal:  Blood       Date:  2005-11-03       Impact factor: 22.113

9.  Therapeutic efficacy of adoptive immunotherapy is predicated on in vivo antigen-specific proliferation of donor T cells.

Authors:  Jørgen Kjaergaard; Liaomin Peng; Peter A Cohen; Suyu Shu
Journal:  Clin Immunol       Date:  2003-07       Impact factor: 3.969

10.  Effect of a perfluorocarbon emulsion (Fluosol-DA) on reticuloendothelial system clearance function.

Authors:  O Castro; A E Nesbitt; D Lyles
Journal:  Am J Hematol       Date:  1984-01       Impact factor: 10.047

View more
  64 in total

1.  MRI stem cell tracking for therapy in experimental cerebral ischemia.

Authors:  Pedro Ramos-Cabrer; Mathias Hoehn
Journal:  Transl Stroke Res       Date:  2011-10-27       Impact factor: 6.829

2.  Cell tracking using (19)F magnetic resonance imaging: technical aspects and challenges towards clinical applications.

Authors:  Houshang Amiri; Mangala Srinivas; Andor Veltien; Mark J van Uden; I Jolanda M de Vries; Arend Heerschap
Journal:  Eur Radiol       Date:  2014-11-06       Impact factor: 5.315

Review 3.  Peripheral Nerve Nanoimaging: Monitoring Treatment and Regeneration.

Authors:  Jelena M Janjic; Vijay S Gorantla
Journal:  AAPS J       Date:  2017-08-04       Impact factor: 4.009

Review 4.  Novel frontiers in ultra-structural and molecular MRI of the brain.

Authors:  Jeff H Duyn; Alan P Koretsky
Journal:  Curr Opin Neurol       Date:  2011-08       Impact factor: 5.710

Review 5.  New frontiers and developing applications in 19F NMR.

Authors:  Jian-Xin Yu; Rami R Hallac; Srinivas Chiguru; Ralph P Mason
Journal:  Prog Nucl Magn Reson Spectrosc       Date:  2012-11-02       Impact factor: 9.795

Review 6.  Tracking immune cells in vivo using magnetic resonance imaging.

Authors:  Eric T Ahrens; Jeff W M Bulte
Journal:  Nat Rev Immunol       Date:  2013-09-10       Impact factor: 53.106

Review 7.  Theranostic nanoparticles for cancer and cardiovascular applications.

Authors:  Dan Wang; Bingbing Lin; Hua Ai
Journal:  Pharm Res       Date:  2014-03-05       Impact factor: 4.200

8.  In Vivo 19F MR Imaging Cell Tracking of Inflammatory Macrophages and Site-specific Development of Colitis-associated Dysplasia.

Authors:  Soo Hyun Shin; Deepak K Kadayakkara; Jeff W M Bulte
Journal:  Radiology       Date:  2016-07-19       Impact factor: 11.105

9.  In vivo 19F MRI for cell tracking.

Authors:  Mangala Srinivas; Philipp Boehm-Sturm; Markus Aswendt; Eberhard D Pracht; Carl G Figdor; I Jolanda de Vries; Mathias Hoehn
Journal:  J Vis Exp       Date:  2013-11-25       Impact factor: 1.355

10.  (19)F-MRI for monitoring human NK cells in vivo.

Authors:  Myriam N Bouchlaka; Kai D Ludwig; Jeremy W Gordon; Matthew P Kutz; Bryan P Bednarz; Sean B Fain; Christian M Capitini
Journal:  Oncoimmunology       Date:  2016-02-18       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.